| Code | Headline | Release Date |
|---|---|---|
GO8 |
40060 NSX Removal from Official List - Removal from Official List Removal from Official List |
27-Sep-2024 4:31:05 PM |
GO8Price Sensitive |
40050 NSX Suspension from Official Quotation - Continued Suspension Continued Suspension |
16-Sep-2024 10:01:29 AM |
GO8Price Sensitive |
40050 NSX Suspension from Official Quotation - Company Suspended from Official List - Failure to pay Annual Listing Fee - 2024/2025 Company Suspended from Official List - Failure to pay Annual Listing Fee - 2024/2025 |
28-Aug-2024 9:48:27 AM |
GO8 |
40572 NSX NTA Notification - NTA 30 June 2024 NTA 30 June 2024 |
31-Jul-2024 4:36:54 PM |
GO8Price Sensitive |
40560 NSX Quarterly Report - Quarterly activities report and Quarterly cash flow Quarterly activities report and Quarterly cash flow report for the period ended 30 June 2024 |
31-Jul-2024 4:36:36 PM |
GO8 |
41999 NSX General Market Disclosure Other - COVIRIX Medical - NIVF Media Release NewGenIvf Provides Further Update on Potential Reverse Merger with COVIRIX on July 23, 2024 |
24-Jul-2024 4:46:19 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 May 2024 NTA 31 May 2024 |
28-Jun-2024 4:09:29 PM |
GO8 |
41999 NSX General Market Disclosure Other - COVIRIX Medical - NIVF Media Release NewGenIvf Provides Update on Status of Potential Reverse Merger with COVIRIX |
21-Jun-2024 2:28:47 PM |
GO8 |
40120 NSX Change in Substantial Shareholder - Notice of change of interests of substantial holder Notice of change of interests of substantial holder - Keith Knowles |
06-Jun-2024 2:23:04 PM |
GO8Price Sensitive |
41999 NSX General Market Disclosure Other - COVIRIX Medical - NIVF Media Release NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with COVIRIX |
04-Jun-2024 2:13:32 PM |
GO8 |
40572 NSX NTA Notification - NTA 30 April 2024 NTA 30 April 2024 |
03-Jun-2024 9:07:01 AM |
GO8Price Sensitive |
40560 NSX Quarterly Report - Quarterly activities report and Quarterly cash flow Quarterly activities report and Quarterly cash flow report for the period ended 31 March 2024 |
30-Apr-2024 4:53:16 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 March 2024 NTA 31 March 2024 |
30-Apr-2024 4:49:15 PM |
GO8 |
40572 NSX NTA Notification - NTA 29 February 2024 NTA 29 February 2024 |
08-Apr-2024 5:06:15 PM |
GO8Price Sensitive |
40540 NSX Half Yearly Report - Appendix 3 and Half yearly report Appendix 3 and Half yearly report for the period ended 31 December 2023 |
15-Mar-2024 2:04:21 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 January 2024 NTA 31 January 2024 |
29-Feb-2024 5:09:47 PM |
GO8Price Sensitive |
40560 NSX Quarterly Report - Quarterly activities report and Quarterly cash flow Quarterly activities report and Quarterly cash flow report for the period ended 31 December 2023 |
31-Jan-2024 4:59:03 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 December 2023 NTA 31 December 2023 |
31-Jan-2024 4:37:45 PM |
GO8Price Sensitive |
40829 NSX Appointment/Resignation Other - CHANGE OF AUDITOR CHANGE OF AUDITOR |
31-Jan-2024 4:35:54 PM |
GO8 |
40572 NSX NTA Notification - NTA 30 November 2023 NTA 30 November 2023 |
29-Dec-2023 2:11:05 PM |
GO8Price Sensitive |
40081 NSX Response to Query - 40081 NSX Response to Query - Response to Price Query - 19 December 2023 Response to Price Query - 19 December 2023 |
20-Dec-2023 11:26:51 AM |
GO8Price Sensitive |
40080 NSX Query - 40080 NSX Query - Price Query - 19 December 2023 Price Query - 19 December 2023 |
20-Dec-2023 11:26:37 AM |
GO8 |
40572 NSX NTA Notification - NTA 31 October 2023 NTA 31 October 2023 |
30-Nov-2023 4:34:41 PM |
GO8 |
40930 NSX Results of Meeting - Results of 2023 AGM Results of 2023 AGM |
27-Nov-2023 9:02:09 AM |
GO8 |
41999 NSX General Market Disclosure Other - Chairman's Address to Shareholders - 2023 AGM Chairman's Address to Shareholders - 2023 AGM |
24-Nov-2023 4:27:00 PM |
GO8Price Sensitive |
40560 NSX Quarterly Report - Quarterly activities report and Quarterly cash flow Quarterly activities report and Quarterly cash flow report for the period ended 30 September 2023 |
31-Oct-2023 3:20:04 PM |
GO8 |
40572 NSX NTA Notification - NTA 30 September 2023 NTA 30 September 2023 |
31-Oct-2023 3:14:29 PM |
GO8Price Sensitive |
40081 NSX Response to Query - Response to Price Query - Trade 30th of October 2023 Response to Price Query - Trade 30th of October 2023 |
31-Oct-2023 10:03:02 AM |
GO8Price Sensitive |
40080 NSX Query - Price Query - Trade 30th of October 2023 Price Query - Trade 30th of October 2023 |
31-Oct-2023 10:02:42 AM |
GO8 |
40910 NSX Notice of Annual General Meeting - AGM Proxy Form - Updated AGM Proxy Form - Updated |
25-Oct-2023 4:35:22 PM |
GO8 |
40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting 2023 Notice of Annual General Meeting 2023 |
24-Oct-2023 4:44:02 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 August 2023 NTA 31 August 2023 |
29-Sep-2023 4:58:36 PM |
GO8Price Sensitive |
40510 NSX Annual Report - Annual Report - 30 June 2023 Annual Report - 30 June 2023 |
29-Sep-2023 8:02:04 AM |
GO8Price Sensitive |
40530 NSX Preliminary/Final Statement - Preliminary Final Report - 30 June 2023 Preliminary Final Report - 30 June 2023 |
13-Sep-2023 6:57:37 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 July 2023 NTA 31 July 2023 |
31-Aug-2023 5:15:53 PM |
GO8Price Sensitive |
41999 NSX General Market Disclosure Other - COVIRIX Medical and Numolux Group Media Release COVIRIX Medical and Numolux Group Media Release |
23-Aug-2023 10:15:22 AM |
GO8 |
40560 NSX Quarterly Report - Quarterly activities report and Quarterly cash flow Quarterly activities report and Quarterly cash flow report for the period ended 30 June 2023 |
01-Aug-2023 8:27:19 AM |
GO8 |
40572 NSX NTA Notification - NTA 30 June 2023 NTA 30 June 2023 |
01-Aug-2023 8:27:04 AM |
GO8 |
40572 NSX NTA Notification - NTA 31 May 2023 NTA 31 May 2023 |
30-Jun-2023 4:46:38 PM |
GO8 |
40572 NSX NTA Notification - NTA 30 April 2023 NTA 30 April 2023 |
30-May-2023 4:33:35 PM |
GO8Price Sensitive |
40560 NSX Quarterly Report - Quarterly activities and Quarterly cash flow Quarterly activities report and Quarterly cash flow report for the period ended 31 March 2023 |
28-Apr-2023 5:13:35 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 March 2023 NTA 31 March 2023 |
28-Apr-2023 5:13:19 PM |
GO8Price Sensitive |
40081 NSX Response to Query - Response from Company to Price & Volume Query Response from Company to Price & Volume Query |
06-Apr-2023 2:25:51 PM |
GO8Price Sensitive |
40080 NSX Query - Price & Volume Query Price & Volume Query |
06-Apr-2023 2:25:33 PM |
GO8 |
40572 NSX NTA Notification - NTA 28 February 2023 NTA 28 February 2023 |
04-Apr-2023 11:06:02 AM |
GO8 |
41999 NSX General Market Disclosure Other - COVIRIX Medical Media Release COVIRIX Medical Media Release |
30-Mar-2023 12:05:52 PM |
GO8 |
40110 NSX Becoming a Substantial Shareholder - Initial Substantial Shareholder Notice Initial Substantial Shareholder Notice - Keith Knowles |
29-Mar-2023 4:41:51 PM |
GO8Price Sensitive |
40540 NSX Half Yearly Report - Appendix 3 and Half yearly report Appendix 3 and Half yearly report for the period ended 31 December 2022 |
16-Mar-2023 2:55:20 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 January 2023 NTA 31 January 2023 |
28-Feb-2023 3:23:46 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 December 2022 NTA 31 December 2022 |
31-Jan-2023 4:20:20 PM |
GO8Price Sensitive |
40560 NSX Quarterly Report - Quarterly activities and Quarterly cash flow Quarterly activities report and Quarterly cash flow report for the period ended 31 December 2022 |
31-Jan-2023 4:19:56 PM |
GO8 |
40750 NSX Details of Share Registry - Change of share registry GO8 to change its share registry will be transferred to BoardRoom share registry effective from 23 January 2023. |
20-Jan-2023 4:50:51 PM |
GO8 |
40572 NSX NTA Notification - NTA 30 November 2022 NTA 30 November 2022 |
30-Dec-2022 12:49:43 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 October 2022 NTA 31 October 2022 |
30-Nov-2022 4:21:38 PM |
GO8 |
40930 NSX Results of Meeting - Results of AGM Results of 2022 AGM |
29-Nov-2022 9:00:57 AM |
GO8Price Sensitive |
41999 NSX General Market Disclosure Other - Chairman's Address to Shareholders Chairman's Address to Shareholders - 2022 AGM |
29-Nov-2022 9:00:23 AM |
GO8Price Sensitive |
40560 NSX Quarterly Report - Quarterly activities report and Quarterly cash flow re Quarterly activities report and Quarterly cash flow report for the period ended 30 September 2022 |
31-Oct-2022 6:58:09 PM |
GO8 |
40572 NSX NTA Notification - NTA 30 September 2022 NTA 30 September 2022 |
31-Oct-2022 6:57:44 PM |
GO8Price Sensitive |
40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting 2022 Notice of Annual General Meeting 2022 |
28-Oct-2022 5:50:56 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 August 2022 NTA 31 August 2022 |
30-Sep-2022 4:17:36 PM |
GO8Price Sensitive |
40510 NSX Annual Report - Annual Report - 30 June 2022 Annual Report - 30 June 2022 |
30-Sep-2022 4:16:58 PM |
GO8Price Sensitive |
40530 NSX Preliminary/Final Statement - Preliminary Final Report - 30 June 2022 Preliminary Final Report - 30 June 2022 |
13-Sep-2022 5:12:19 PM |
GO8 |
40599 NSX Periodic Disclosure Other - Annual Nominated Adviser Statement for 2022 - 2023 Annual Nominated Adviser Statement for 2022 - 2023 |
05-Sep-2022 10:39:33 AM |
GO8 |
40572 NSX NTA Notification - NTA 31 July 2022 NTA 31 July 2022 |
31-Aug-2022 2:57:12 PM |
GO8Price Sensitive |
40560 NSX Quarterly Report - Quarterly activities and Quarterly cash flow Quarterly activities report and Quarterly cash flow report for the period ended 30 June 2022 |
29-Jul-2022 4:04:38 PM |
GO8 |
40572 NSX NTA Notification - NTA 30 June 2022 NTA 30 June 2022 |
29-Jul-2022 4:04:20 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 May 2022 NTA 31 May 2022 |
30-Jun-2022 4:10:36 PM |
GO8Price Sensitive |
41999 NSX General Market Disclosure Other - COVIRIX Medical and DiaCarta Inc partnership COVIRIX Medical and DiaCarta Inc take their partnership from local to global |
10-Jun-2022 12:40:22 PM |
GO8Price Sensitive |
41999 NSX General Market Disclosure Other - Pitt Street Research values COVIRIX Medical Pitt Street Research values COVIRIX Medical at US$5.46- US$8.45 per share |
06-Jun-2022 11:00:25 AM |
GO8 |
40572 NSX NTA Notification - NTA 30 April 2022 NTA 30 April 2022 |
31-May-2022 11:40:06 AM |
GO8Price Sensitive |
40560 NSX Quarterly Report - Quarterly activities and Quarterly cash flow Quarterly activities report and Quarterly cash flow report for the period ended 31 March 2022 |
29-Apr-2022 4:17:42 PM |
GO8 |
40572 NSX NTA Notification - NTA 31 March 2022 NTA 31 March 2022 |
29-Apr-2022 3:49:33 PM |
GO8 |
40572 NSX NTA Notification - NTA 28 February 2022 NTA 28 February 2022 |
31-Mar-2022 1:28:19 PM |
GO8Price Sensitive |
40540 NSX Half Yearly Report - Appendix 3 and Half yearly report Appendix 3 and Half yearly report for the period ended 31 December 2021 |
16-Mar-2022 4:29:40 PM |
GO8 |
41999 NSX General Market Disclosure Other - COVIRIX reports successful test results COVIRIX reports successful test results against Delta variant further confirming previous successful tests on SARS CoV-2 |
08-Mar-2022 1:52:13 PM |
GO8Price Sensitive |
40572 NSX NTA Notification - NTA 31 January 2022 NTA 31 January 2022 |
28-Feb-2022 1:24:55 PM |
GO8Price Sensitive |
40560 NSX Quarterly Report - Quarterly activities and Quarterly cash flow Quarterly activities report and Quarterly cash flow report for the period ended 31 December 2021 |
31-Jan-2022 9:15:44 AM |
GO8Price Sensitive |
40572 NSX NTA Notification - NTA 31 December 2021 NTA 31 December 2021 |
31-Jan-2022 9:14:25 AM |
GO8 |
40380 NSX Exercise of Options - Quotation of Additional Securities The Board of Directors of GoConnect Ltd (GO8) are pleased to advise that Sino Investment Services Pty Ltd (SIS) has converted 40 million options it held in GO8 into fully paid ordinary shares at an exercise price of 2 cents per option into shares. |
06-Jan-2022 12:21:53 PM |
GO8 |
40150 NSX Section 205G Notice Change in Director's Interests - Richard Li Change in Director's Interests - Richard Li |
06-Jan-2022 10:49:59 AM |
GO8 |
40099 NSX Official List Other - Amended Letter of Application - Share quantity Amended Letter of Application - Share quantity |
05-Jan-2022 10:04:21 AM |
GO8 |
40020 NSX Commencement of Official Quotation - Amended Commencement of Quotation - Share quantity Amended Commencement of Quotation - Share quantity |
05-Jan-2022 8:59:04 AM |
GO8 |
40099 NSX Official List Other - Issuers Undertaking Issuers Undertaking |
31-Dec-2021 12:36:15 PM |
GO8 |
40024 NSX Nominated Adviser's Declaration - Nominated Adviser Declaration Nominated Adviser Declaration |
31-Dec-2021 12:36:06 PM |
GO8 |
40099 NSX Official List Other - Holding Range Analysis Holding Range Analysis |
31-Dec-2021 12:35:51 PM |
GO8 |
40520 NSX Top 20 Shareholders - Top 20 Shareholders Top 20 Shareholders |
31-Dec-2021 12:35:43 PM |
GO8 |
40110 NSX Becoming a Substantial Shareholder - Initial Substantial Shareholder Notice - Leet Investments Pty Limited Initial Substantial Shareholder Notice - Leet Investments Pty Limited |
31-Dec-2021 12:35:36 PM |
GO8 |
40110 NSX Becoming a Substantial Shareholder - Initial Substantial Shareholder Notice - SSI Nominees Pty Ltd Initial Substantial Shareholder Notice - SSI Nominees Pty Ltd |
31-Dec-2021 12:35:29 PM |
GO8Price Sensitive |
40023 NSX Director's Declaration & Undertaking - Director's Declaration - Kevin Wong Director's Declaration - Kevin Wong |
31-Dec-2021 12:35:21 PM |
GO8 |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - Kevin Wong Initial Director's Interests - Kevin Wong |
31-Dec-2021 12:35:12 PM |
GO8Price Sensitive |
40023 NSX Director's Declaration & Undertaking - Director's Declaration - Richard Li Director's Declaration - Richard Li |
31-Dec-2021 12:35:04 PM |
GO8 |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - Richard Li Initial Director's Interests - Richard Li |
31-Dec-2021 12:34:53 PM |
GO8Price Sensitive |
40023 NSX Director's Declaration & Undertaking - Director's Declaration - Philip Chan Director's Declaration - Philip Chan |
31-Dec-2021 12:34:45 PM |
GO8 |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - Philip Chan Initial Director's Interests - Philip Chan |
31-Dec-2021 12:34:34 PM |
GO8Price Sensitive |
40510 NSX Annual Report - Annual Report - 30 June 2021 Annual Report - 30 June 2021 |
31-Dec-2021 12:34:24 PM |
GO8 |
40510 NSX Annual Report - Annual Report - 30 June 2020 Annual Report - 30 June 2020 |
31-Dec-2021 12:34:15 PM |
GO8Price Sensitive |
40510 NSX Annual Report - Annual Report - 30 June 2019 Annual Report - 30 June 2019 |
31-Dec-2021 12:34:08 PM |
GO8 |
40022 NSX Articles of Association/Constitution - Company Constitution Company Constitution |
31-Dec-2021 12:33:55 PM |
GO8 |
40099 NSX Official List Other - Information Memorandum Information Memorandum |
31-Dec-2021 12:33:47 PM |
GO8 |
40099 NSX Official List Other - Letter of Application Letter of Application |
31-Dec-2021 12:33:39 PM |
GO8 |
40020 NSX Commencement of Official Quotation - Commencement of Quotation - 11am AEDT Wednesday, 5th of January 2022 Commencement of Quotation - 11am AEDT Wednesday, 5th of January 2022 |
31-Dec-2021 12:33:28 PM |